Denise Braendgaard: NNHF Marks Defining Moment at ASH2025
Denise Braendgaard, General Manager of Novo Nordisk Haemophilia & Haemoglobinopathies Foundation, posted on LinkedIn:
”A defining moment at ASH2025 in Orlando
We proudly unveiled a major NNHF milestone – one that marks the start of an exciting new chapter with even greater impact.
Being there alongside some of my incredible team was a true privilege: Célia Rohrer, Llyord Mwaniki, Sara Motka. The way we unite is how we deliver on our mission: Impacting care. Together
Our event, Unveiling New Horizons, was a powerful reminder of why this journey into haemophilia – and now haemoglobinopathies – matters so deeply. The passion and commitment from our Council members, partners and experts reaffirmed that we are on the right path.
Our compact NNHF booth was small in size but big in purpose. From morning to evening, every conversation was extremely meaningful, shaping the next steps in our strategic approach across low- and middle-income countries. I loved reconnecting with long-standing partners and meeting new collaborators who share our vision for sustainable solutions.
Every interaction reminds us why partnership matters and why our mission is worth every effort. Inspired by your enthusiasm, we are committed to going above and beyond to achieve our shared goals.
Thank you to everyone joining this journey with purpose, passion, and impact: Together, we aim to reach four times more people worldwide.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026